Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

January 17, 2020

Civica Rx partners with Thermo Fisher Scientific to develop and manufacture drugs with a history of drug shortages

Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.

Civica Rx partners with Thermo Fisher Scientific to develop and manufacture drugs with a history of drug shortages